Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Shares of Synergy Pharmaceuticals jumped 47% on encouraging, late-state study results for its constipation drug.
read more
SGS Life Science Services has announced the planned opening of its new bio/pharmaceutical quality control laboratory at Villeneuve La Garenne, a Paris suburb, replacing an existing facility in Clichy.
read more
Allergan is buying Kythera Biopharmaceuticals for about $2.1 billion, adding a drug that destroys fat cells and eliminates the cosmetic condition referred to as "double chin".
read more
BioMarin shares neared an all-time high after announcing positive results from a mid-stage study for its drug to treat the most common form of dwarfism.
read more
A survey of biopharmaceutical dealmakers by Campbell Alliance, the consulting firm of inVentiv Health, suggests that 2015 will set a new record for mergers and acquisitions and licensing of biopharmaceutical assets.
read more
The U.S. Food and Drug Administration, in partnership with international regulatory and law enforcement agencies, took action against more than 1,050 websites that illegally sell potentially dangerous, unapproved prescription medicines and medical ...
read more
A high-ranking Senate Democrat is probing retailers and online companies about sales of dubious dietary supplements, especially those promising seniors protection from memory loss, dementia and other age-related problems.
read more
Sandoz, a Novartis company, has announced the US launch of GlatopaTM, the first generic version of Teva's Copaxone® (glatiramer acetate injection) 20 mg/ml one-time-daily multiple sclerosis therapy.
read more
Alexza Pharmaceuticals has updated and amended its ADASUVE® (Staccato® loxapine) commercial partnerships with Grupo Ferrer Internacional, S.A. and Teva Pharmaceutical Industries Ltd.
read more
Intas Pharmaceuticals has launched RAZUMAB™, its biosimilar to Lucentis® (Ranibizumab). Intas is the first company globally to develop and launch a biosimilar version of Ranibizumab.
read more
Study Connect™, a new mobile app from Merge eClinical, allows eClinicalOS (eCOS) users to perform a wide array of clinical trial management functions from their iOS-based mobile devices.
read more
Metrics Contract Services (Metrics) has purchased state-of-the-art analytical laboratory equipment to better serve pharmaceutical clients whose drug products now must undergo heightened elemental impurities testing, thanks to new international ...
read more
The House on Tuesday approved a bipartisan bill that would update regulation of harmful chemicals for the first time in nearly 40 years.
read more
Forty-five percent of Americans who use opioid prescription painkillers do not realize they are taking an opioid, or that the drug is just as addictive as heroin, according to a National Safety Council survey
read more
Medical marijuana has not been proven to work for many illnesses that state laws have approved it for, according to the first comprehensive analysis of research on its potential benefits.
read more